Petar Svorcan

2.0k total citations
34 papers, 206 citations indexed

About

Petar Svorcan is a scholar working on Epidemiology, Surgery and Genetics. According to data from OpenAlex, Petar Svorcan has authored 34 papers receiving a total of 206 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 10 papers in Surgery and 9 papers in Genetics. Recurrent topics in Petar Svorcan's work include Inflammatory Bowel Disease (9 papers), Microscopic Colitis (7 papers) and Liver Disease Diagnosis and Treatment (7 papers). Petar Svorcan is often cited by papers focused on Inflammatory Bowel Disease (9 papers), Microscopic Colitis (7 papers) and Liver Disease Diagnosis and Treatment (7 papers). Petar Svorcan collaborates with scholars based in Serbia, Australia and United States. Petar Svorcan's co-authors include Mladen Davidović, Vladan Vukčević, Dragan Djordjević, Jelena Djordjevic, Katarina Veljović, Nada Dimković, Marijana Protić, Ivan Soldatović, Maja Tolinački and Nataša Golić and has published in prestigious journals such as Gastroenterology, International Journal of Molecular Sciences and Endoscopy.

In The Last Decade

Petar Svorcan

31 papers receiving 193 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petar Svorcan Serbia 10 67 53 52 44 33 34 206
Imran Paruk South Africa 9 67 1.0× 49 0.9× 31 0.6× 51 1.2× 37 1.1× 17 219
Yusuf Usta Türkiye 9 46 0.7× 66 1.2× 34 0.7× 68 1.5× 42 1.3× 25 263
Hua-Tuo Zhu China 9 101 1.5× 100 1.9× 17 0.3× 80 1.8× 20 0.6× 18 292
Ganesh Bhat India 10 149 2.2× 109 2.1× 86 1.7× 26 0.6× 25 0.8× 37 268
Shun Ito Japan 9 137 2.0× 86 1.6× 28 0.5× 55 1.3× 27 0.8× 38 343
Imad Asaad United States 8 203 3.0× 63 1.2× 75 1.4× 26 0.6× 15 0.5× 29 274
Elli Karatza Greece 7 130 1.9× 37 0.7× 96 1.8× 87 2.0× 15 0.5× 15 284
C Smyth Ireland 9 61 0.9× 110 2.1× 23 0.4× 29 0.7× 121 3.7× 21 377
Pei‐Mei Shi China 8 129 1.9× 70 1.3× 112 2.2× 26 0.6× 12 0.4× 14 229
Bilal Ergül Türkiye 10 82 1.2× 174 3.3× 19 0.4× 40 0.9× 32 1.0× 37 315

Countries citing papers authored by Petar Svorcan

Since Specialization
Citations

This map shows the geographic impact of Petar Svorcan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petar Svorcan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petar Svorcan more than expected).

Fields of papers citing papers by Petar Svorcan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petar Svorcan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petar Svorcan. The network helps show where Petar Svorcan may publish in the future.

Co-authorship network of co-authors of Petar Svorcan

This figure shows the co-authorship network connecting the top 25 collaborators of Petar Svorcan. A scholar is included among the top collaborators of Petar Svorcan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petar Svorcan. Petar Svorcan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marković, Srdjan, et al.. (2025). Telehealth—An Environmentally Friendly Way to Take Care of Patients with Inflammatory Bowel Disease. Medicina. 61(2). 332–332. 1 indexed citations
2.
3.
Perović, Milan, et al.. (2025). Is Deep Remission the Right Time to De-Escalate Biologic Therapy in IBD? A Single-Center Retrospective Study. Biomedicines. 13(8). 1928–1928. 1 indexed citations
4.
Mitrović, M.M., et al.. (2025). Exploring the Potential of Oral Butyrate Supplementation in Metabolic Dysfunction-Associated Steatotic Liver Disease: Subgroup Insights from an Interventional Study. International Journal of Molecular Sciences. 26(12). 5561–5561. 1 indexed citations
5.
6.
7.
Svorcan, Petar, et al.. (2024). The effects of synbiotics on the liver steatosis, inflammation, and gut microbiome of metabolic dysfunction-associated liver disease patients-randomized trial. Romanian Journal of Internal Medicine. 62(2). 184–193. 13 indexed citations
8.
Graham, David Y., Saleh A. Naser, Thomas J. Borody, et al.. (2024). Randomized, Double-Blind, Placebo-Controlled Study of Anti-Mycobacterial Therapy (RHB-104) in Active Crohn’s Disease. Antibiotics. 13(8). 694–694. 3 indexed citations
9.
Marković, Srdjan, et al.. (2023). P704 The effect of antiTNFα and anti-integrin agents on liver steatosis in inlamatory bowel disease patients with non-alcoholic fatty liver disease. Journal of Crohn s and Colitis. 17(Supplement_1). i837–i837. 2 indexed citations
10.
Tolinački, Maja, Nataša Golić, Svetlana Soković Bajić, et al.. (2022). The Impact of Synbiotic Treatment on the Levels of Gut-Derived Uremic Toxins, Inflammation, and Gut Microbiome of Chronic Kidney Disease Patients—A Randomized Trial. Journal of Renal Nutrition. 33(2). 278–288. 27 indexed citations
11.
Knežević, Tamara, et al.. (2022). P330 Immunity in patients with inflammatory bowel disease on biologic therapy after COVID, 19 vaccination. Journal of Crohn s and Colitis. 16(Supplement_1). i349–i349. 1 indexed citations
12.
Mijailović, Željko, et al.. (2020). Micro-elimination of HCV as a possible therapeutic strategy: our experience and a review of literature. The Journal of Infection in Developing Countries. 14(2). 117–124. 3 indexed citations
13.
Svorcan, Petar, et al.. (2017). The influence of intraabdominal pressure on the mortalityrate of patients with acute pancreatitis. TURKISH JOURNAL OF MEDICAL SCIENCES. 47(3). 748–753. 6 indexed citations
14.
Fabri, Milotka, et al.. (2015). Boceprevir in genotype 1 chronic hepatitis C: First experiences in Serbia. Srpski arhiv za celokupno lekarstvo. 143(1-2). 35–41. 2 indexed citations
15.
Lazarević, Ivana, Jelena Djordjević, Maja Ćupić, et al.. (2013). The influence of single and combined IL28B polymorphisms on response to treatment of chronic hepatitis C. Journal of Clinical Virology. 58(1). 254–257. 8 indexed citations
16.
Protić, Marijana, Sonja Pavlović, Daniela Bojic, et al.. (2008). CARD15 gene polymorphisms in Serbian patients with Crohnʼs disease: genotype–phenotype analysis. European Journal of Gastroenterology & Hepatology. 20(10). 978–984. 12 indexed citations
17.
Svorcan, Petar, et al.. (2007). Is there such thing as “Reversible Dementia” (RD)?. Archives of Gerontology and Geriatrics. 44. 271–277. 3 indexed citations
18.
Trbojević‐Stanković, Jasna, et al.. (2007). A quantitative morphometric study of rectal mucosa in adult and aged healthy subjects.. PubMed. 22(4). 433–6. 4 indexed citations
19.
Protić, Marijana, et al.. (2000). Mechanism of diarrhea in microscopic colitis. Gastroenterology. 118(4). A377–A377. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Imran Paruk Breakdown of academic impact, for papers by Yusuf Usta Breakdown of academic impact, for papers by Hua-Tuo Zhu Breakdown of academic impact, for papers by Ganesh Bhat Breakdown of academic impact, for papers by Shun Ito Breakdown of academic impact, for papers by Imad Asaad Breakdown of academic impact, for papers by Elli Karatza Breakdown of academic impact, for papers by C Smyth Breakdown of academic impact, for papers by Pei‐Mei Shi Breakdown of academic impact, for papers by Bilal Ergül
Rankless by CCL
2026